Renal Resistive Index as a Predictor of Acute Kidney Injury and Evaluation of Fluid Administration in Sepsis
NCT ID: NCT06009445
Last Updated: 2023-08-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
45 participants
OBSERVATIONAL
2023-07-01
2024-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Predictive Value of Doppler RSI for Prediction of AKI in Septic Patients in ICU
NCT04426032
Renal Resistive Index as a Predictor of Acute Renal Impairment in High-risk Patients
NCT06386796
Dynamic Change of Doppler-based Renal Resistive Index in Predicting Renal Recovery
NCT05866250
Doppler-based Renal Resistive Index in Assessing Renal Dysfunction Reversibility in ICU Patients
NCT02355314
The Role of Renal Resistive Index (RI) in Predicting Acute Kidney Injury Progression in Intensive Care Clinic
NCT06995222
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AKI group
Acute kidney injury (AKI) was defined according to the Kidney Disease Improving Global Outcome (KDIGO) classification using both creatinine and urine output criteria.
The KDIGO guidelines define AKI as follows:
* Increase in serum creatinine by ≥0.3 mg/dL (≥26.5 micromol/L) within 48 hours, or
* Increase in serum creatinine to ≥1.5 times baseline, which is known or presumed to have occurred within the prior seven days, or
* Urine volume \<0.5 mL/kg/hour for six hours
Renal resistive index
The calculation formula for Renal resistive index (RRI) as follows :
(systolic peak flow velocity \_ diastolic minimum flow velocity )/systolic peak flow velocity .
will be measured with ultrasound-Doppler using an abdominal curvilinear probe ultrasonography by two independent, trained sonographers (who will not be involved in patient care. After visualizing the kidney in ultrasound mode and checking for renal abnormalities, an arcuate or interlobar artery will be localized and three successive doppler measurements at different positions in the kidney (high, middle and low) will be performed, 3 times in each kidney. So a total number of 9 RRI values will be obtained in each kidney.
The median value of each section will be used and the 3 median values of each kidney will be averaged.
Non AKI group
Patients who will no develop Acute kidney injury (AKI).
Renal resistive index
The calculation formula for Renal resistive index (RRI) as follows :
(systolic peak flow velocity \_ diastolic minimum flow velocity )/systolic peak flow velocity .
will be measured with ultrasound-Doppler using an abdominal curvilinear probe ultrasonography by two independent, trained sonographers (who will not be involved in patient care. After visualizing the kidney in ultrasound mode and checking for renal abnormalities, an arcuate or interlobar artery will be localized and three successive doppler measurements at different positions in the kidney (high, middle and low) will be performed, 3 times in each kidney. So a total number of 9 RRI values will be obtained in each kidney.
The median value of each section will be used and the 3 median values of each kidney will be averaged.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Renal resistive index
The calculation formula for Renal resistive index (RRI) as follows :
(systolic peak flow velocity \_ diastolic minimum flow velocity )/systolic peak flow velocity .
will be measured with ultrasound-Doppler using an abdominal curvilinear probe ultrasonography by two independent, trained sonographers (who will not be involved in patient care. After visualizing the kidney in ultrasound mode and checking for renal abnormalities, an arcuate or interlobar artery will be localized and three successive doppler measurements at different positions in the kidney (high, middle and low) will be performed, 3 times in each kidney. So a total number of 9 RRI values will be obtained in each kidney.
The median value of each section will be used and the 3 median values of each kidney will be averaged.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* meet Sepsis 3 criteria (potential source of infection , host response and organ dysfunction) but not in septic shock.
Exclusion Criteria
* patients with hepatorenal syndrome.
* Poor abdominal echogenicity eg.(morbid obesity ,increase intra abdominal pressure )
* Severe acute or chronic renal insufficiency .
* Dialysis dependency.
* Renal transplantation.
* Known renal artery stenosis.
* Mono-kidney, kidney tumor, anatomic kidney abnormalities.
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tanta University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Safinaz Abdelkhalek Aboelfetoh
Resident of Anesthesiology, Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Safinaz A Aboelfetoh, MBBCh
Role: PRINCIPAL_INVESTIGATOR
Anesthesiology, Faculty of Medicine, Tanta University, Egypt.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tanta University Hospitals
Tanta, Elgharbia, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
36264MS189/5/23
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.